GSK plc - Nov 7, 2022 Form 3 Insider Report for Spero Therapeutics, Inc. (SPRO)

Role
10%+ Owner
Signature
Victoria Whyte, Authorized Signatory, GSK plc
Stock symbol
SPRO
Transactions as of
Nov 7, 2022
Transactions value $
$0
Form type
3
Date filed
11/14/2022, 04:05 PM
Previous filing
Sep 20, 2022
Next filing
Jan 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SPRO Common Stock 9.19M Nov 7, 2022 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported herein are held of record by GSK Equity Investments, Limited, and Glaxo Group Limited, each of which is an indirect, wholly-owned subsidiary of GSK plc (the "Reporting Person").